Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F24D0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,668
Award facts
- Contract value 100% obligated
- $41,667.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,667.97 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on December 22, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery from its corporate office location in the same city. The contract falls under the company's substantial $999.999 billion indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which operates through December 2026 and serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical supplies to military healthcare programs worldwide.
This delivery order for Zepbound, a diabetes medication, exemplifies AmerisourceBergen Drug Corp's role as a critical vendor within the federal medical supply chain, particularly for Defense Health Agency and other government healthcare systems. The award reflects the contractor's demonstrated capability to meet federal procurement requirements through open competition and its extensive portfolio of pharmaceutical product deliveries under firm fixed-price arrangements. As a child contract under the larger DLA pharmaceutical prime vendor vehicle, this award supports the agency's mission to provide medical supplies to military personnel and veterans while maintaining supply chain efficiency through established vendor relationships.
Quick answers
Who was awarded contract SPE2DR26F24D0?
SPE2DR26F24D0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F24D0 worth?
The government has obligated $41,668 on SPE2DR26F24D0.
Is contract SPE2DR26F24D0 an order under another contract?
Yes. SPE2DR26F24D0 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F24D0 competed?
The extent of competition for SPE2DR26F24D0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award